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Abstract
Background: The stability of reference genes has a tremendous effect on the results of relative quantification of
genes expression by quantitative polymerase chain reaction. Equine Inflammatory Airway Disease (IAD) is a
common condition often treated with corticosteroids. The diagnosis of IAD is based on clinical signs and
bronchoalveolar lavage (BAL) fluid cytology. The aim of this study was to identify reference genes with the most
stable mRNA expression in the BAL cells of horses with IAD irrespective of corticosteroids treatment.
Results: The expression stability of seven candidate reference genes (B2M, HPRT, GAPDH, ACTB, UBB, RPL32, SDHA)
was determined by qRT-PCR in BAL samples taken pre- and post- treatment with dexamethasone and fluticasone
propionate for two weeks in 7 horses with IAD. Primers’ efficiencies were calculated using LinRegPCR. NormFinder,
GeNorm and qBasePlus softwares were used to rank the genes according to their stability. GeNorm was also used
to determine both the ideal number and the best combination of reference genes. GAPDH was found to be the
most stably expressed gene with the three softwares. GeNorm ranked B2M as the least stable gene. Based on the
pair-wise variation cut-off value determined with GeNorm, the number of genes required for optimal normalization
was four and included GAPDH, SDHA, HPRT and RPL32.
Conclusion: The geometric mean of GAPDH, HPRT, SDHA and RPL32 is recommended for accurate normalization
of quantitative PCR data in BAL cells of horses with IAD treated with corticosteroids. If only one reference gene can
be used, then GAPDH is recommended.
Background
Inflammatory Airway Disease (IAD) is a non-septic lung
disease defined for the first time in 2002 [1] and that
affects the lower airways in horses [2]. The syndrome is
later defined in a consensus publication [2] as moderate
lower airway neutrophilic inflammation or any lower
airway inflammation with mast or eosinophilic cells, not
associated with signs of labored breathing at rest. IAD
affects a large number of horses and can impede their
performance [3-5]. Because the IAD phenotype has only
been described recently, its pathophysiology is still not
understood and is under investigation. Knowledge of
molecular mechanisms underlying this disease is a
fundamental prerequisite to understand the etiology and
the underlying inflammatory mechanism involved in
IAD. Recently, the first evidence for a corticosteroids
treatment suppressing the airway hyperreactivity
featured in IAD has been established (Tohver T., New
D., Nicol J., McDonald K., Fernandez N., Léguillette R.:
Dexamethasone and fluticasone significantly decrease
airway hyperresponsiveness in horse with inflammatory
airway disease (IAD), submitted). Tohver et al. found a
significant reduction in airway hyperreactivity and air-
way hypersensitivity after treatment with either intra-
muscular dexamethasone or inhaled fluticasone
propionate in horses with IAD. However, neither of the
treatments affected the differential cell count in
the bronchoalveolar lavage fluid (BALF). Understanding
the pathophysiology of IAD as well as the mechanism of
action of corticosteroids in this disease implies a better
understanding of the inflammatory cells activity. Two
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cytokines and chemokines in inflammatory cells from
the BALF in horses with recurrent airway obstruction
after treatment with corticosteroids [6,7], but this is still
to be studied in IAD.
Real-time quantitative PCR is a standard method for
accurate, sensitive and rapid quantification of gene
expression nowadays [8,9]. Relative quantification using
PCR allows comparing genes expression between
groups, for example before and after a treatment. When
analyzing data for relative quantification, results are nor-
malized to a reference. Normalization is extremely
important to allow accurate comparison of the results
between different samples and conditions in gene
expression studies [10]. There have been a lot of differ-
ent strategies proposed for normalizing, that range from
ensuring that a similar sample size is chosen to the use
of an internal reference gene [10]. Normalizing to a
reference gene is a widely used method because it is
simple in theory. An ideal reference gene should be sta-
bly expressed and unaffected by experimental protocol
or disease status [11]. Commonly used reference genes
such as GAPDH and b-actin are unfortunately often
used without prior validation of their expression stability
under the specific study conditions. However, a number
of studies have shown that the expression of those
genes is significantly altered in some experimental con-
ditions [12-15]. It is therefore necessary to validate the
expression stability of reference genes prior to their use
in an experimental protocol. Ideally, it has been recently
recommended that a combination of reference genes
should be used to obtain a more stable reference [16].
Regarding horses, a number of potential reference
genes have been studied in different tissues and cell cul-
tures including normal skin and sarcoids [17], colon,
heart, kidney, liver, lung, lymph node, small intestine
and spleen [18] and also in peripheral blood mononuc-
lear cells [18-20]. However, although many studies are
using the BALF as a sample of choice to study the activ-
ity of cells in the lungs, the most reliable reference
g e n e si ne q u i n eB A L Fh a v en o tb e e ns t u d i e d .I na d d i -
tion, robust reference genes are needed when using cor-
ticosteroids because of the extensive effects these
medications have on cellular metabolism.
The aim of this study was therefore to validate refer-
ence genes for gene expression studies in BALF of
horses with IAD irrespective of treatment with dexa-
methasone (DEX) or fluticasone propionate (FLUC).
Results
Bronchoalveolar lavage fluid total and differential cell
counts
The results of the BALF cytological analysis are shown
in figure 1 and table 1. The BALF total and differential
cell counts were not significantly different between the
DEX and FLUC treatment baseline values. The percen-
tage lymphocytes in the BALF decreased significantly
after DEX (p = 0.039) (figure 1 and table 1). Treatment
with DEX and FLUC did not induce any significant
change in total cell count or differential cell count for
any other cell type in the BALF.
Purity and quantity of extracted RNA
The optical density (OD) ratio A260/A280 nm measured
with a Nanodrop spectrophotometer was 1.95 ± 0.12
(OD A260/A280 ratio ± SD). The average RNA concen-
tration after extraction using the RNeasy Mini Kit was
57.14 μg/μl ± 41.48 (μg/μl ± SD).
Amplification efficiency
The amplification efficiencies for individual reactions
were calculated using the LinRegPCR software. The
results of the averaged efficiencies are shown in table 2.
The amplification efficiencies for the seven candidate
reference genes ranged between 96.15% ± 5.74 (effi-
ciency % ± SD) and 103.45% ± 5.54 (efficiency % ± SD).
Expression levels of candidate reference genes
The cycle threshold (Ct) values obtained throughout the
study were low enough to pursue the analysis reliably:
Overall and by combining pre- and post-treatment Ct
values for each gene, out of the seven genes studied,
B2M (mean Ct 17.08) and UBB (mean Ct 17.56) were
expressed at the highest levels, followed by ACTB
(mean Ct 17.56), RPL32 (mean Ct 19.36), GAPDH
(mean Ct 20.72) and SDHA (mean Ct 21.74). HPRT
(mean Ct 22.95) was expressed at the lowest level in the
Figure 1 Bronchoalveolar lavage fluid differential cell counts in
horses with IAD pre- and post- treatment with corticosteroids.
DEX indicates dexamethasone. FLUC indicates fluticasone. Bars
indicate standard deviation. The figure shows the differential cell
counts for neutrophils, lymphocytes, macrophages, mast cells and
eosinophils as a percentage of the total amount of nucleated cells.
* indicates a significant difference between pre- and post-
treatment (p < 0.05).
Beekman et al. BMC Molecular Biology 2011, 12:5
http://www.biomedcentral.com/1471-2199/12/5
Page 2 of 10cells of the BALF (figure 2). Prior to any referencing,
there was no significant difference in average Ct value
between SDHA and GAPDH as well as between b-actin,
UBB and B2M. Also, the average Ct values for HPRT
and RPL32 were significantly different from all the other
candidate reference genes.
Identification of optimal reference genes
Figure 3A shows the ranking of the seven candidate
reference genes based on their stability values
calculated using NormFinder. GAPDH has the lowest
stability value and therefore is the most stably
expressed gene (stability value: 0.013) followed by
RPL32 (stability value: 0.025), HPRT (stability value:
0.027), B2M (stability value: 0.028), SDHA (stability
value: 0.033) and ACTB (stability value: 0.034). UBB
has the highest stability value (at 0.04) and is there-
fore the least stably expressed. The best combination
of two genes was GAPDH and RPL32 with a stability
value of 0.014.
Table 1 BALF cell counts in 7 horses with IAD before and after treatment with corticosteroids
Lymphocytes (%) Macrophages (%) Neutrophils (%) Mast cells (%) Eosinophils (%) Total Cell Count (cells/mm
3)
Dexamethasone
Day 1
Horse 1 56.17 29.14 13.84 0.36 0.18 298.9
Horse 2 53.35 27.02 17.78 1.85 0.00 441.1
Horse 3 30.09 62.39 5.69 1.65 0.18 150.0
Horse 4 45.49 30.45 3.95 3.95 0.00 113.3
Horse 5 68.09 9.98 21.03 0.98 0.00 231.1
Horse 6 56.83 21.39 17.82 1.98 0.00 142.2
Horse 7 66.52 21.23 10.94 1.31 0.00 122.2
Mean ± SEM 53.79 ± 4.91 * 28.80 ± 6.17 13.01 ± 2.44 1.73 ± 0.43 0.05 ± 0.01 214.1 ± 45.5
Day 15
Horse 1 52.74 16.44 29.45 1.37 0.00 212.2
Horse 2 17.01 78.07 4.30 0.20 0.20 1026.7
Horse 3 22.12 62.82 15.06 0.00 0.00 204.4
Horse 4 40.72 13.80 40.50 4.75 0.00 90
Horse 5 48.16 1.64 46.72 3.48 0.00 162.2
Horse 6 52.21 15.50 32.10 0.18 0.00 35.6
Horse 7 56.30 30.87 12.17 0.65 0.00 110
Mean ± SEM 41.32 ± 5.94 * 31.31 ± 10.73 25.76 ± 5.92 1.52 ± 0.71 0.03 ± 0.01 263.0 ± 129.5
Fluticasone Day 1
Horse 1 66.42 13.18 20.40 0.00 0.00 246.7
Horse 2 75.55 7.64 14.30 2.51 0.00 378.9
Horse 3 60.68 11.14 17.50 10.45 0.23 42.2
Horse 4 54.39 6.34 35.12 4.15 0.00 104.4
Horse 5 54.84 14.75 19.12 11.29 0.00 167.8
Horse 6 67.00 5.30 24.60 3.30 0.00 48.9
Horse 7 58.50 20.70 19.60 1.10 0.00 93.3
Mean ± SEM 62.48 ± 2.89 11.29 ± 2.06 21.52 ± 2.55 4.69 ± 1.68 0.03 ± 0.01 154.6 ± 46.0
Day 15
Horse 1 69.34 8.42 21.84 0.40 0.00 156.7
Horse 2 45.35 45.35 7.88 1.41 0.00 143.3
Horse 3 62.71 14.29 22.76 0.24 0.00 123.3
Horse 4 58.33 14.47 23.90 3.07 0.22 133.3
Horse 5 40.04 47.00 10.83 2.13 0.00 n/a
Horse 6 60.60 1.10 36.00 1.90 0.40 20.1
Horse 7 66.40 9.10 23.00 1.50 0.00 56.7
Mean ± SEM 57.54 ± 4.11 19.96 ± 6.98 20.89 ± 3.51 1.52 ± 0.37 0.09 ± 0.02 105.6 ± 22.2
* indicates a significant difference between pre- and post- treatment (p < 0.05).
Beekman et al. BMC Molecular Biology 2011, 12:5
http://www.biomedcentral.com/1471-2199/12/5
Page 3 of 10Figure 3B shows the ranking of the seven candidate
reference genes based on their M value calculated using
GeNorm. All the candidate reference genes started with
an M value below 1.5, which is the default limit below
which candidate reference genes can be classified as sta-
bly expressed. GeNorm ranks GAPDH and SDHA as
the most stably expressed candidate reference genes, fol-
lowed by HPRT, RPL32 and UBB. B2M and ACTB were
the least stably expressed candidate reference genes.
The qBaseplus software was used to confirm the
results obtained with GeNorm and NormFinder soft-
wares. The unstable genes B2M and ACTB were not
included in the evaluation. Based on the coefficient of
variation (CV) value calculated in qBaseplus GAPDH
was, in agreement with GeNorm and NormFinder, the
most stably expressed gene in the study (table 3).
Determination of the optimal number of reference genes
for normalization
In addition to the stability results, the GeNorm software
can determine the optimal number of reference genes
necessary to calculate a normalization factor. The results
Table 2 Primers information and PCR reactions efficiencies for candidate reference genes
Gene Accession Number Oligo Sequence Amplicon size (bp) Efficiency ± SD (%)
ACTB AF035774 Forward CTGGCACCACACCTTCTACA 249 96.15 ± 5.74
Reverse CCCTCATAGATGGGCACAGT
GAPDH AF083897 Forward GGTGAAGGTCGGAGTAAACG 106 96.25 ± 4.63
Reverse AATGAAGGGGTCATTGATGG
B2M X69083 Forward CCTGCTCGGGCTACTCTC 89 103.45 ± 5.54
Reverse CATTCTCTGCTGGGTGACG
HPRT AY372182 Forward AATTATGGACAGGACTGAACGG 121 101.05 ± 3.27
Reverse ATAATCCAGCAGGTCAGCAAAG
RPL32 CX594263 Forward GGGAGCAATAAGAAAACGAAGC 138 101.25 ± 2.45
Reverse CTTGGAGGAGACATTGTGAGC
SDHA DQ402987 Forward GAGGAATGGTCTGGAATACTG 91 100.5 ± 1.96
Reverse GCCTCTGCTCCATAAATCG
UBB AF506969 Forward TTCGTGAAGACCCTGACC 91 100.65 ± 2.35
Reverse CCTTATCCTGGATCTTGGC
Primers sequences were determined using primer3 software and Ensembl Genome Browser (EMBL accession numbers are indicated). Efficiencies are averages of
all individual efficiencies calculated for each reaction using LinReqPCR software.
Figure 2 Average cycle threshold (Ct) values of candidate
reference genes tested in the bronchoalveolar lavage fluid of
horses with IAD. The values are RT-PCR cycle threshold numbers
(Ct values) pre-and post-treatment in horses with IAD treated with
corticosteroids. The bars indicate standard deviation. Letters indicate
a significant difference in average Ct value. Average Ct values that
have the same letter are not significantly different.
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Figure 3 Ranking of seven candidate reference genes using
NormFinder and GeNorm softwares. (A) NormFinder ranks the
genes based on a calculated stability value. The lower the stability
value, the higher the expression stability. (B) GeNorm ranks the
candidate reference genes based on their stability parameter M. The
lower the M value, the higher the expression stability.
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most stable genes GAPDH, SDHA, HPRT and RPL32,
h a v eap a i r w i s ev a r i a t i o nv a l u el o w e rt h a nt h ec u to f f
v a l u eo f0 . 1 5 .I na d d i t i o n ,t h e r ei sav e r yg o o da g r e e -
ment between GeNorm and NormFinder softwares iden-
tifying three out of four most stable genes, namely
GAPDH, HPRT and RPL32. We therefore conclude that
the combination of GAPDH, HPRT, SDHA and RPL32
is the most appropriate normalization approach for gene
expression studies in BALF of horses with inflammatory
lung diseases treated with corticosteroids.
Discussion
Using reference genes that have a stable expression
between the compared groups is crucial in gene expression
studies. Several studies have shown that the use of differ-
ent reference genes can change the outcome and conclu-
sions of a study [21-25]. The aim of the present study was
therefore to validate, for the first time, reference genes for
studies in BALF of horses with IAD, irrespective of treat-
ment with corticosteroids. We found that using GAPDH,
HPRT, SDHA and RPL32 as a combination of reference
genes is the most appropriate normalization approach in
this experimental design and that GAPDH is the single
most stably expressed gene in the BALF of horses treated
with corticosteroids. Although the present study only used
7 horses, which is less than typical studies using mice or
human samples, it is comparable to other clinical studies
in equine medicine using PCR on 3 to 10 horses
[17,19,20,26,27]. Compared to other techniques measuring
gene expression, the PCR technique is better suited for
samples of smaller size and the number of horses used
here allowed obtaining significant findings that are rele-
vant for studies in the field of equine medicine.
To our knowledge, there are only two studies evaluat-
ing the stability of reference genes in horse tissues, one
being in the skin [17] and the other being in the periph-
eral blood [19]; no data is available on the stability of
reference genes in the lungs of horses to compare our
results with. However, Cappelli at al. found GAPDH as
the least stably expressed gene in the panel of candidate
reference genes they tested in equine blood lymphocytes
during exercise-induced stress [19]. This emphasizes the
importance of appropriate reference gene validation for
every tissue and experimental protocol, even when using
t h es a m es p e c i e s .T h ed i s c r e p a n c yi sp r o b a b l yd u ei n
this case to the difference in tissues tested as well as to
the effect of corticosteroids on cellular metabolism. In
addition, a few studies assessed the validity of proposed
housekeeping genes in the bronchoalveolar cells of
humans with various pathologies [21,28,29]. Using a dif-
ferent method than reported here, a study found that
GAPDH was the most stable reference gene in the
bronchoalveolar samples of people with nonsmall cell
lung cancer [29]. Another study used Genorm to test
candidate housekeeping genes that were mostly different
from those described here and found that GNB2L1,
HPRT1 and RPL32 were the most stably expressed
genes in alveolar macrophages from 22 subjects with
chronic obstructive pulmonary disease (COPD) [28];
they also described that GAPDH was inappropriate for
these studies. In agreement, one study found that
GAPDH and ACTB were not suitable as reference genes
in asthma and illustrated it by showing that the use of
GAPDH vs ACTB as reference genes would lead to con-
flicting results [22]. Lastly, a study used equivalence test
as well as the statistical tools BestKeeper, GeNorm and
NormFinder to assess the most suitable housekeeping
genes in the lungs of a large number of people (2 cohort
studies) irrespective of gender, smoking, lung patholo-
gies, treatments, and BAL cytology [21]. This study only
shared 3 reference genes with the data presented here,
but found that only RPL32 along with the proteasome
Table 3 Candidate reference genes stability results using
qBaseplus software
Reference target M value CV value
GAPDH 0.695 0.274
HPRT 0.830 0.476
RPL32 0.781 0.364
SDHA 0.828 0.388
UBB 0.816 0.347
M values, which is a parameter for the gene stability, and Coefficient of
Variation (CV) values, which indicates how stably a gene is expressed, show
that GAPDH is the most stably expressed gene.
Figure 4 Determination of the optimal number of reference
genes for normalization. The GeNorm software calculates the
normalization factor from an increasing number of genes (starting
with at least two) for which the variable V defines the pairwise
variation between two sequential normalization factors. The lower
the pairwise variation, the better is the combination of genes for
reference. V4/5 for example, shows the variation between the
normalization factors of four genes in relation to five genes and
shows that four genes is the combination providing the lowest
pairwise variation.
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samples [21]. In this sense, RPL32 came as the second
and third most stably expressed gene in the NormFinder
and GeNorm analysis presented here.
Numerous methods are available to validate reference
genes for relative quantification by QPCR. Studies will
often use only one method, but one study compared
two reference genes validation methods in horse sam-
ples [19] and another compared four methods in
humans BAL samples [21]. Similarly, to ensure consis-
tency and for comparison purpose, the data was ana-
l y z e dh e r eu s i n gt h r e ed i f f e r e n ts o f t w a r e s( G e N o r m ,
NormFinder and qBasePlus). GeNorm and qBasePlus
u s eap a i r w i s ec o m p a r i s o nm odel, while NormFinder
uses a model-based approach. In our study, GeNorm 1)
identified GAPDH, SDHA, HPRT and RPL32 as the
most stably expressed reference genes by calculating a
stability parameter (M) (see methods) and 2) determined
that the optimal number of reference genes to be used
was 4 (GAPDH, SDHA, HPRT and RPL32), by calculat-
ing pair-wise variation (V values) (see methods). Norm-
Finder defined GAPDH as the best reference gene when
using the treatment with corticosteroids as group identi-
fiers to calculate a stability value for each candidate
reference gene. NormFinder takes into account variation
across subgroups, thus avoiding artificial selection of co-
regulated genes by analyzing the expression stability of
candidate genes independently from each other [16].
Lastly, qBasePlus confirmed that GAPDH is the best
reference gene in our study design. Similarly to previous
studies [19,30], we found a good agreement in the refer-
ence genes ranking between GeNorm and NormFinder
as they both ranked GAPDH as the most stable
expressed gene, which was confirmed by the qBasePlus
analysis. We also found that the first three most stable
reference genes were consist e n t l yt h es a m ew h e nu s i n g
GeNorm and NormFinder, even if they were not in the
exact same ranking order. There was a slight difference
in the top four most stably expressed genes as the four
most stably expressed genes ranked by NormFinder were,
in decreasing order, GAPDH, RPL32, HPRT and B2M,
while they were GAPDH, SDHA, HPRT and RPL32 with
GeNorm. Very similar discrepancy between the different
algorithms has been observed in other studies comparing
statistical analysis methods: The only study using horse
samples and comparing GeNorm with NormFinder
found also that the best three reference genes were
ranked differently by the two algorithms and that there
was disagreement on the fourth most stable gene [19].
Another study using BAL samples on a large cohort of
human patients also found different ranking order and
genes identification for the top four most stable reference
genes [21]. Such discrepancy could be explained by
genes’ co-regulation. Indeed, co-regulated genes may
become highly ranked independently of their expression
stabilities with GeNorm software [31]. In contrast, results
obtained with NormFinder are not significantly affected
by co-regulation of candidate reference genes. In our
s t u d y ,t h em a i nd i f f e r e n c ei nr a n k i n gi n v o l v e dS D H A ,
which ranked as the fifth most stable gene with Norm-
Finder, but ranked second with GeNorm. Although co-
regulation has been described for ACTB, B2M, GAPDH
and HPRT, we did not find evidence for the possible co-
regulation of SDHA in the literature. To check for possi-
ble co-regulation of SDHA, we analyzed the data again
with GeNorm, this time excluding SDHA from the candi-
date reference gene panel. We found that removing
SDHA from the analysis did not resolve the discrepancy
in ranking of the candidate reference genes between
NormFinder and GeNorm (data not shown). We thus
concluded that the discrepancy in ranking was not
caused by co-regulation of SDHA.
ACTB and UBB were ranked by both softwares as
unstably expressed genes and therefore should not be
used as reference in gene expression studies in bronch-
oalveolar lavage (BAL) cells obtained from horses with
IAD, which is similar (for ACTB) as another study using
humans BAL samples [21]. It is however in contrast
with a study done in normal horses’ skin in which
ACTB and UBB came out as the most stably expressed
genes from the panel tested with GeNorm [17]. GAPDH
was however not evaluated in this previous study [17].
This shows again that the choice of reference genes can-
not be transposed from on study to the other without
validation for the specifics of each experimental
protocol.
As described above, GeNorm also provides a measure
for the best number of reference genes that should be
used for optimal normalization. In agreement with sev-
eral previous studies, we found that the use of more
than one reference gene allows for a more accurate nor-
malization than the use of only one reference gene
[10,16,31]. Based on a cut-off point of 0.15 for the V
value, as described by Vandesompele et al [16], a combi-
nation of the four most stable reference genes was cal-
culated as being optimal for gene expression studies in
BAL cells of horses with IAD treated with corticoster-
oids (figure 4).
Conclusion
In conclusion, we recommend using the geometric mean
of GAPDH, HPRT, SDHA and RPL32 to guarantee sui-
table normalization in bronchoalveolar lavage cells
obtained from horses with IAD treated with either DEX
o rF L U C .I fo n l yo n er e f e r e n c eg e n ec a nb eu s e d ,
GAPDH should be chosen because it is unanimously the
most stably expressed reference gene tested for this type
of studies.
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This study was approved by the Animal Care Commit-
tee of the Health Science Centre at the University of
Calgary. The authors used the REFLECT statement
guidelines to report this study [32].
Sample collection
Bronchoalveolar lavage (BAL) samples were taken from 7
horses with IAD. The number of horses was calculated
using a power of 0.9 for a difference in measured para-
meters between baseline and treatments of 2 times the
within-patient standard deviation. Horses were mixed
breeds, 4 mares, 3 geldings of various ages (range: 4-16
year old). Criteria for inclusion followed the recommenda-
tions from a consensus publication and were: 1- the pre-
sence of respiratory clinical signs during exercise without
labored breathing at rest 2- the absence of increased lung
resistance at rest after a challenge with moldy hay 3- the
presence of airway hyperreactivity measured by an
increase in lung resistance (RL) by 75% at lower doses of
nebulized histamine 4- a BAL with increased percentage
of mast cells (> 2%) and/or eosinophils (>0.1%) and/or
neutrophils (>10%). The study used a randomized cross-
over design as follow: The 7 horses were randomly divided
into two groups (using Microsoft
® excel randomization
function) which were each subjected to two treatment
protocols sequentially but separated in the middle by a
three weeks washout period. A baseline BAL was per-
formed as described below before each treatment period
on day -1. Dexamethasone (0.05 mg/kg) was administered
intra muscularly once a day in the morning (between 7:00
and 8:00 AM) for 15 days. Fluticasone (3000 μg) was
administered by inhalation using an Aerohippus
® twice
daily (between 7:00 and 8:00 AM and PM) for 15 days. A
second BAL was performed on day 15.
The BAL procedure was done as previously described
[5]. Briefly, the BAL was performed after sedating the
horses using a flexible videoendoscope that was passed
through a nostril and directed into the lung until it was
wedged into the main bronchus. An instillation of lido-
caine solution through the channel of the endoscope was
done to desensitize the airway mucosa during the pro-
gression of the endoscope. After wedging of the endo-
scope 250 ml of 0.9% sterile sodium chloride was instilled
into the bronchus and aspirated via the endoscope biopsy
channel by use of a suction pump and collected in a 500
ml plastic Nalgene
® jar. This process was repeated with a
second bolus of sterile saline. Samples were immediately
stored at 4°C until further processing in the laboratory
which was done within 2 hours of the BAL procedure.
Slides were prepared for the total and differential cell
counts using a sample of BAL fluid that had been put in
a vacutainer
® EDTA tube right after the BAL procedure.
Slides were prepared using a cytospin
® (1000 rpm for
4 minutes) and stained using an automatic stainer
(Hema-Tek
® 2000, Bayer) with a Modified Wright
Giemsa solution for better visualization of the mast
cells. Differential counts were performed on at least 400
nucleated cells, not including epithelial cells.
Two 50 ml aliquots of BALF were centrifuged at 700 g
for 10 minutes (GP Centrifuge, Beckman, USA) before
removing the supernatant and resuspending the cells pel-
let in 1.5 ml of RNAlater (Qiagen, Mississauga, Ontario,
Canada). The samples were immediately frozen at -80°C.
RNA extraction
The RNA extractions were performed at a later time
(approximately 3 months after the BAL procedure). The
samples were thawed at room temperature, centrifu-
gated, and the RNAlater supernatant was aspirated. The
cells from the pellet were homogenized using the needle
and syringe method. Total RNA was extracted using the
RNeasy mini kit (Qiagen) according to the manufac-
turer’s recommendations. The yield and the purity of
the extracted RNA were measured using the Nanodrop
ND-1000 spectrophotometer (Thermoscientific, Wil-
mington, USA) by optical density (OD) A260/A280 nm.
First-strand cDNA synthesis
An average of 435 ± 109.6 ng (± SD) total RNA for each
sample was retro-transcribed immediately after the RNA
extraction using the Omniscript RT Kit (Qiagen) com-
bined with Oligo(dT)12-18 Primers (Invitrogen, Burling-
ton, Ontario, Canada) and RNaseOUT Recombinant
Ribonuclease Inhibitor (Invitrogen) according to the
manufacturer’s specifications. cDNA was stored at -80°C
until further use.
Reference gene selection and primer design
No previous study validated reference genes in the BAL
fluid of horses, and more “traditional” reference genes
like GAPDH and ACTB have been most often used in
equine respiratory medicine [33-38]. Regarding other
e q u i n eo r g a n s ,H P R T ,B 2 M ,S D H A ,U B B ,a n dR P L 3 2
have been previously compared in peripheral blood [19],
and rNA 18S, 28S, B2M, ACTB, GAPDH and HPRT1
have been studied by one group on various horse tissues
[18]. The genes selected in our study were based on these
previous studies and were from different functional
classes to minimize the possibility of co-regulation.
Designing primers for reference genes is more challen-
ging in horses than in laboratory animals or humans
because of the less detailed sequences information avail-
able. Information about the candidate reference genes
used in the present study is shown in table 2. The follow-
ing seven commonly used reference genes were selected:
b-actin (ACTB), glyceraldehyde-3P-dehydrogenase
(GAPDH), hypoxanthine ribosyltransferase (HPRT), b-2-
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subunit A (SDHA), ubiquitin B (UBB) and ribosomal
protein L32 (RPL32). Primers for equine HPRT, B2M,
SDHA, UBB, and RPL32 were previously described [19].
Primers for ACTB and GAPDH were designed using the
Primer3 software [39] based on horse sequences from the
Ensembl Genome Browser [40]. The primers were
designed so that the predicted amplicons would span
exon-exon boundaries. They were tested using a BLAST
analysis against the Ensembl database and verified using
MFold [41]. The optimal primer annealing temperatures
were determined on cDNA from BAL samples obtained
from horses with IAD. Melting curve analysis as well as
agarose gel electrophoresis were performed to test for the
specificity of the amplicons.
Real-time quantitative PCR
One microliter of cDNA was added to 13 μlP e r f e C t a ™
SYBR
® Green Super Mix Low ROX, 40 nM of the for-
ward primer, 40 nM of the reverse primer and 7 μlo f
nuclease free water to a final volume of 25 μl. The PCR
reactions were performed on a MX3005P machine (Stra-
t a g e n e ,L aJ o l l a ,C A ,U S A ) .P C Rc o n d i t i o n sw e r e :I n i t i a l
denaturation at 95°C for 5 minutes to activate the DNA
polymerase, followed by 45 cycles of denaturation at 95°
C for 1 minute, annealing at the primer specific annealing
temperature for 30 seconds and extension at 70°C for 30
seconds. After the last cycle the melting curve was deter-
mined in the range 60°-95°C. For GAPDH and ACTB we
used the same protocol, only the annealing temperature
was 64°C instead of 62°C. All the reactions were executed
in triplicate. Negative control samples were always
included in each run to check for contamination.
Data analysis
The raw RT-QPCR amplification data was exported
from the MxPro
® software (Stratagene) to Microsoft
®
excel. The software LinRegPCR was used to calculate
the efficiencies for all the reactions individually. Lin-
RegPCR is a freeware that uses non-baseline corrected
data to perform a baseline correction on each sample,
then determines a window-of-linearity and finally uses
linear regression analysis to fit a straight line trough the
PCR data set. From the slope of this line the PCR effi-
ciency of each individual sample is calculated [42]. The
average of the individual efficiencies for each candidate
reference gene was used for the gene expression levels
analysis. The efficiency-corrected Ct-values were con-
verted to a linear scale using the ΔCt-method. The
averages of the ΔCt-values for each triplicate were used
for stability comparison of candidate reference genes in
the NormFinder, GeNorm and qBasePlus softwares.
NormFinder uses an ANOVA-based model [31]. The
software calculates a stability value for all candidate
reference genes tested. The stability value is based on
the combined estimate of intra- and inter-group expres-
sion variations of the genes studied. A low stability
value, indicating a low combined intra- and inter-group
variation, indicates high expression stability.
GeNorm calculates the stability using a pairwise com-
parison model [16]. This program selects the two most
stable genes or a combination of multiple stable genes
from a panel of candidate reference genes for normaliza-
tion. The ranking of the genes is based on the gene stabi-
lity parameter M. Stepwise exclusion of the gene with the
highest M value and recalculation results in a ranking of
the candidate reference genes. Lower M values represent
higher expression stabilities. To determine the optimal
number of reference genes required for accurate normali-
zation, the program calculates the pairwise variation Vn/n
+1 between sequential normalization factors containing an
increasing number of reference genes. A large variation
means that the added gene has a significant effect and
should preferably be included for calculation of a reliable
normalization factor. If Vn/n+1 < 0.15 the inclusion of an
additional reference gene is not required and the recom-
mended number of reference genes is given by n.
qBasePlus is a program designed for qPCR data man-
agement and analysis and was developed based on algo-
rithms from GeNorm and qBase [43]. To determine the
expression stability of the candidate reference genes
qBasePlus calculates an M value, similar to the one cal-
culated by the GeNorm software, for all the candidate
genes. In addition, the qBasePlus software calculates a
coefficient of variation (CV) for all the genes. This CV
value indicates how stably each gene is expressed. We
used this program to confirm and compare it with the
results obtained by the GeNorm and Normfinder soft-
ware. We used the cut-off values of 0.7 and 40% respec-
tively for the M and CV values below which a gene is
considered stably expressed. Only the expression stabi-
lity of the 5 most stable expressed candidate reference
genes (GAPDH, HPRT, RPL32, SDHA and UBB) was
evaluated using this program.
Statistical analysis
Statistical analysis of reference genes stability and ranking
was provided by GeNorm, NormFinder, and qBasePlus. In
addition, differences in average Ct values of candidate
reference genes were calculated using an ANOVA fol-
lowed by a Bonferroni Pairwise Comparison Test. Differ-
ences in BAL differential cell counts before/after
treatment were calculated using a Wicoxon Signed Rank
test. P values of less than 0.05 were considered significant.
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